Harmanjit Singh

11.4k total citations
97 papers, 1.1k citations indexed

About

Harmanjit Singh is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Harmanjit Singh has authored 97 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Surgery. Recurrent topics in Harmanjit Singh's work include Diabetes Treatment and Management (9 papers), Corneal surgery and disorders (6 papers) and Glaucoma and retinal disorders (5 papers). Harmanjit Singh is often cited by papers focused on Diabetes Treatment and Management (9 papers), Corneal surgery and disorders (6 papers) and Glaucoma and retinal disorders (5 papers). Harmanjit Singh collaborates with scholars based in India, United States and Canada. Harmanjit Singh's co-authors include Harbans Lal, Lyle H. Miller, Ashish Kumar Kakkar, Ekta Arora, Larry D. Bowers, Pugazhenthan Thangaraju, Iqbal Ike K. Ahmed, Jasbir Singh, Saurabh Aggarwal and Claudine E. Fasching and has published in prestigious journals such as SHILAP Revista de lepidopterología, Circulation Research and Ophthalmology.

In The Last Decade

Harmanjit Singh

89 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harmanjit Singh India	16	218	173	141	115	103	97	1.1k
Ashish Kumar Kakkar India	16	178 0.8×	113 0.7×	232 1.6×	64 0.6×	84 0.8×	72	976
Pooja Gupta India	20	239 1.1×	166 1.0×	76 0.5×	109 0.9×	124 1.2×	145	1.4k
Jonathan Kopel United States	19	261 1.2×	155 0.9×	246 1.7×	45 0.4×	112 1.1×	126	1.5k
Erle C.H. Lim Singapore	20	240 1.1×	98 0.6×	181 1.3×	128 1.1×	134 1.3×	58	1.4k
Sidsel Rogde Norway	18	73 0.3×	97 0.6×	115 0.8×	79 0.7×	45 0.4×	42	1.1k
John Posner United Kingdom	26	302 1.4×	283 1.6×	136 1.0×	121 1.1×	197 1.9×	80	2.0k
Maria Cristina Maggio Italy	17	453 2.1×	138 0.8×	152 1.1×	63 0.5×	301 2.9×	61	1.6k
Vincenzo Costigliola Germany	20	368 1.7×	148 0.9×	80 0.6×	30 0.3×	96 0.9×	43	1.5k
Parviz Ghahramani United Kingdom	20	386 1.8×	269 1.6×	398 2.8×	82 0.7×	39 0.4×	39	2.1k
Milou‐Daniel Drici France	21	534 2.4×	118 0.7×	264 1.9×	92 0.8×	104 1.0×	73	1.6k

Countries citing papers authored by Harmanjit Singh

Since Specialization

Citations

This map shows the geographic impact of Harmanjit Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harmanjit Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harmanjit Singh more than expected).

Fields of papers citing papers by Harmanjit Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harmanjit Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harmanjit Singh. The network helps show where Harmanjit Singh may publish in the future.

Co-authorship network of co-authors of Harmanjit Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Harmanjit Singh. A scholar is included among the top collaborators of Harmanjit Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harmanjit Singh. Harmanjit Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Singh, Harmanjit, et al.. (2024). Risk of new onset diabetes mellitus with pitavastatin as compared to atorvastatin and rosuvastatin: a systematic review and meta-analysis. Expert Review of Clinical Pharmacology. 17(12). 1–9.

Kaur, Puneet, Navjot Kaur, Harmanjit Singh, & Jasmeen Kaur. (2024). To assess the availability of antibiotics for online sale and comparison of e-pharmacies on key characteristics influencing safe and rational use of antibiotics: an exploratory analysis. JAC-Antimicrobial Resistance. 6(5). dlae158–dlae158.

Singh, Harmanjit, et al.. (2023). Finding the most cost-effective option from commonly used Dipeptidyl peptidase-4 inhibitors in India: a systematic study. Expert Review of Endocrinology & Metabolism. 18(4). 347–354. 3 indexed citations

Singh, Harmanjit, et al.. (2023). Ketamine Augmentation of Electroconvulsive Therapy: A Scoping Review of Dose-Dependent Effects in Major Depressive Disorder. Cureus. 15(6). e40087–e40087. 2 indexed citations

Marchand, Michael, et al.. (2021). Micropulse trans-scleral laser therapy outcomes for uncontrolled glaucoma: a prospective 18-month study. Canadian Journal of Ophthalmology. 56(6). 371–378. 12 indexed citations

Singh, Harmanjit, et al.. (2021). Potential Role of Dexamphetamine in the Treatment of Non-alcoholic Fatty Liver Disease: Hopes and Pitfalls. touchREVIEWS in Endocrinology. 17(1). 33–33. 1 indexed citations

Kakkar, Ashish Kumar, Harmanjit Singh, & Bikash Medhi. (2018). Old wines in new bottles: Repurposing opportunities for Parkinson's disease. European Journal of Pharmacology. 830. 115–127. 19 indexed citations

Singh, Harmanjit, et al.. (2016). Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease. Journal of Natural Science Biology and Medicine. 7(1). 4–4. 23 indexed citations

Singh, Harmanjit, et al.. (2015). Laser iridotomy to treat uveitis-glaucoma-hyphema syndrome secondary to reverse pupillary block in sulcus-placed intraocular lenses: Case series. Journal of Cataract & Refractive Surgery. 41(10). 2215–2223. 20 indexed citations

10.

Sharma, Atul, Ekta Arora, & Harmanjit Singh. (2015). Hypersensitivity reaction with deferasirox. Journal of Pharmacology and Pharmacotherapeutics. 6(2). 105–106. 10 indexed citations

11.

Singh, Harmanjit, et al.. (2014). Sofosbuvir: A novel treatment option for chronic hepatitis C infection. Journal of Pharmacology and Pharmacotherapeutics. 5(4). 278–284. 151 indexed citations

12.

Singh, Harmanjit, et al.. (2014). Inter-Eye Differences in Patients with Pseudoexfoliation Syndrome Presenting with Intraocular Lens Dislocation. Ophthalmology. 122(3). 480–485. 19 indexed citations

13.

Aggarwal, Saurabh & Harmanjit Singh. (2010). Approach to urinary tract infections. Indian Journal of Nephrology. 20(2). 118–118. 18 indexed citations

14.

Singh, Harmanjit, et al.. (1999). The Measurement of Nitrite in Adulterated Urine Samples by High-Performance Ion Chromatography. Journal of Analytical Toxicology. 23(3). 137–140. 15 indexed citations

15.

Singh, Harmanjit & Linda J. Johnson. (1997). Solid-Phase Extraction of THC Metabolite from Urine using the Empore Disk Cartridge Prior to Analysis by GC-MS. Journal of Analytical Toxicology. 21(5). 384–387. 9 indexed citations

16.

Singh, Harmanjit, et al.. (1989). Symptomatic extreme bradycardia in obstructive jaundice.. PubMed. 37(10). 675–675. 1 indexed citations

17.

Singh, Harmanjit. (1975). Methadone-Induced Behavioral Changes: Circular Movements, Aggression, and Electrophysiological Aspects. International Journal of the Addictions. 10(4). 659–673. 3 indexed citations

18.

Singh, Harmanjit, Lyle H. Miller, & Harbans Lal. (1972). Drug addiction : clinical and socio-legal aspects. 9 indexed citations

19.

Singh, Harmanjit, Lyle H. Miller, & Harbans Lal. (1972). Drug addiction : experimental pharmacology. 96 indexed citations

20.

Singh, Harmanjit, Lyle H. Miller, & Harbans Lal. (1972). Clinical and socio-legal aspects. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact